Blanca Espinet
Overview
Explore the profile of Blanca Espinet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
1909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Calvo X, Garcia-Gisbert N, Parraga I, Gibert J, Florensa L, Andrade-Campos M, et al.
Blood Adv
. 2020 Oct;
4(20):5285-5296.
PMID: 33108455
Oligomonocytic chronic myelomonocytic leukemia (OM-CMML) is defined as those myelodysplastic syndromes (MDSs) or myelodysplastic/myeloproliferative neoplasms, unclassifiable with relative monocytosis (≥10% monocytes) and a monocyte count of 0.5 to <1 ×...
32.
Agathangelidis A, Chatzidimitriou A, Gemenetzi K, Giudicelli V, Karypidou M, Plevova K, et al.
Blood
. 2020 Sep;
137(10):1365-1376.
PMID: 32992344
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain major stereotyped subsets often display remarkably consistent...
33.
Nadeu F, Martin-Garcia D, Clot G, Diaz-Navarro A, Duran-Ferrer M, Navarro A, et al.
Blood
. 2020 Jun;
136(12):1419-1432.
PMID: 32584970
Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1 rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non-nodal MCL (nnMCL), that differ in their...
34.
Gonzalez-Gascon-Y-Marin I, Munoz-Novas C, Figueroa I, Hernandez-Sanchez M, Rodriguez-Vicente A, Quijada-Alamo M, et al.
Clin Lymphoma Myeloma Leuk
. 2020 May;
20(8):548-555.e4.
PMID: 32389671
Background: The discovery of new biologic variables with high prognostic effect has been accompanied by the emergence of different prognostic indexes (PIs) to assess the time to first treatment in...
35.
Leeksma A, Baliakas P, Moysiadis T, Puiggros A, Plevova K, van der Kevie-Kersemaekers A, et al.
Haematologica
. 2020 Jan;
106(1):87-97.
PMID: 31974198
Complex karyotype (CK) identified by chromosome-banding analysis (CBA) has shown prognostic value in chronic lymphocytic leukemia (CLL). Genomic arrays offer high-resolution genome-wide detection of copy-number alterations (CNAs) and could therefore...
36.
Fuster C, Martin-Garcia D, Balague O, Navarro A, Nadeu F, Costa D, et al.
Haematologica
. 2019 Nov;
105(8):e408-e411.
PMID: 31753927
No abstract available.
37.
Costa D, Grau J, Espinet B, Arias A, Gomez C, Lopez-Guerra M, et al.
Oncol Lett
. 2019 Jun;
17(6):5705-5710.
PMID: 31186796
gene fusion is the hallmark of chronic myeloid leukemia (CML), and is generated in 5-10% of patients by a variant translocation involving 9q34, 22q11.2 and one or more additional genomic...
38.
Curto-Barredo L, Segura S, Ishii N, Hashimoto T, Mascaro Jr J, Espinet B, et al.
J Dermatol
. 2019 Apr;
46(6):531-534.
PMID: 31021002
Hypereosinophilic syndrome (HES) is often associated with cutaneous manifestations, mostly pruritic lesions, urticaria and angioedema. Mucosal lesions are rarely seen in HES but, when present, are usually the first manifestation...
39.
Clave S, Rodon N, Pijuan L, Diaz O, Lorenzo M, Rocha P, et al.
Clin Lung Cancer
. 2019 Mar;
20(4):e421-e429.
PMID: 30898567
Background: Detection of ALK and ROS1 gene rearrangements in non-small-cell lung cancer is required for directing patient care. Although fluorescence in situ hybridization (FISH) and immunohistochemistry have been established as...
40.
Baliakas P, Jeromin S, Iskas M, Puiggros A, Plevova K, Nguyen-Khac F, et al.
Blood
. 2019 Jan;
133(11):1205-1216.
PMID: 30602617
Recent evidence suggests that complex karyotype (CK) defined by the presence of ≥3 chromosomal aberrations (structural and/or numerical) identified by using chromosome-banding analysis (CBA) may be relevant for treatment decision-making...